Talking siRNAs with the CEO of Silence Therapeutics
Craig Tooman describes Silence's two lead programs targeting Lp(a) and polycythemia vera, as well as how the company is trying to execute on a broader platform.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.